Plus Therapeutics Inc. buy BiotechBee
Start price
10.10.22
/
50%
€8.85
Target price
31.12.24
€15.00
Performance (%)
-46.85%
End price
21.12.22
€4.70
Summary
This prediction ended on 21.12.22 with a price of €4.70. The BUY prediction by BiotechBee for Plus Therapeutics Inc. performed very badly with a performance of -46.85%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Plus Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1.764% | 2.259% | 15.213% | 61.619% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 3.293% | 100.420% |
| iShares Nikkei 225® | -2.451% | 4.086% | 17.198% | 50.705% |
| iShares S&P 500 | -2.252% | -0.151% | 0.574% | 63.730% |
According to BiotechBee what are the pros and cons of Plus Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year